Skip to main content
OpenTrials

Clinical trial condition

Recurrent Salivary Gland Carcinoma

Explore clinical trials studying Recurrent Salivary Gland Carcinoma. Study availability and eligibility vary by location and protocol.

13 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Salivary Gland Carcinoma trial results

Active, Not Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT00588770

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 781 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions